Callan Family Office’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4M | Buy |
42,810
+19,884
| +87% | +$15.5M | 1.05% | 14 |
|
|
2025
Q1 | $18.9M | Buy |
22,926
+421
| +2% | +$348K | 1.42% | 12 |
|
|
2024
Q4 | $17.4M | Buy |
22,505
+21,742
| +2,850% | +$16.8M | 1.11% | 15 |
|
|
2024
Q3 | $676K | Buy |
763
+178
| +30% | +$158K | 0.11% | 86 |
|
|
2024
Q2 | $530K | Buy |
585
+294
| +101% | +$266K | 0.1% | 81 |
|
|
2024
Q1 | $226K | Buy |
+291
| New | +$226K | 0.05% | 88 |
|